AAAAAA

   
Results: 1-20 |
Results: 20

Authors: STARK H LIGNEAU X ARRANG JM SCHWARTZ JC SCHUNACK W
Citation: H. Stark et al., GENERAL CONSTRUCTION PATTERN OF HISTAMINE H-3-RECEPTOR ANTAGONISTS - CHANGE OF A PARADIGM, Bioorganic & medicinal chemistry letters, 8(15), 1998, pp. 2011-2016

Authors: STARK H HULS A LIGNEAU X PURAND K PERTZ H ARRANG JM SCHWARTZ JC SCHUNACK W
Citation: H. Stark et al., DEVELOPMENT OF FUB-181, A SELECTIVE HISTAMINE H-3-RECEPTOR ANTAGONISTOF HIGH ORAL IN-VIVO POTENCY WITH 4-(OMEGA-(ARYLALKYLOXY)ALKYL)-1H-IMIDAZOLE STRUCTURE, Archiv der pharmazie, 331(6), 1998, pp. 211-218

Authors: STARK H ELZ S PERTZ H LIGNEAU X ARRANG JM SCHWARTZ JC SCHUNACK W
Citation: H. Stark et al., CIPROXIFAN, A SELECTIVE ANTAGONIST OF HIGH IN-VITRO AND IN-VIVO POTENCY AT HISTAMINE H-3-RECEPTORS, Naunyn-Schmiedeberg's archives of pharmacology, 358(1), 1998, pp. 99-99

Authors: LIGNEAU X LIN JS VANNIMERCIER G JOUVET M MUIR JL GANELLIN CR STARK H ELZ S SCHUNACK W SCHWARTZ JC
Citation: X. Ligneau et al., NEUROCHEMICAL AND BEHAVIORAL-EFFECTS OF CIPROXIFAN, A POTENT HISTAMINE H-3-RECEPTOR ANTAGONIST, The Journal of pharmacology and experimental therapeutics, 287(2), 1998, pp. 658-666

Authors: KRAUSE M LIGNEAU X STARK H GARBARG M SCHWARTZ JC SCHUNACK W
Citation: M. Krause et al., 4-ALKYNYLPHENYL IMIDAZOLYLPROPYL ETHERS AS SELECTIVE HISTAMINE H-3-RECEPTOR ANTAGONISTS WITH HIGH ORAL CENTRAL-NERVOUS-SYSTEM ACTIVITY, Journal of medicinal chemistry, 41(21), 1998, pp. 4171-4176

Authors: STARK H HULS A LIGNEAU X ARRANG JM SCHWARTZ JC SCHUNACK W
Citation: H. Stark et al., SEARCH FOR NOVEL LEADS FOR HISTAMINE H-3 RECEPTOR ANTAGONISTS - OXYGEN-CONTAINING DERIVATIVES, Die Pharmazie, 52(7), 1997, pp. 495-500

Authors: STARK H LIGNEAU X LIPP R ARRANG JM SCHWARTZ JC SCHUNACK W
Citation: H. Stark et al., SEARCH FOR NOVEL LEADS FOR HISTAMINE H-3 RECEPTOR ANTAGONISTS - AMINEDERIVATIVES, Die Pharmazie, 52(6), 1997, pp. 419-423

Authors: ROULEAU A GARBARG M LIGNEAU X MANTION C LAVIE P ADVENIER C LECOMTE JM KRAUSE M STARK H SCHUNACK W SCHWARTZ JC
Citation: A. Rouleau et al., BIOAVAILABILITY, ANTINOCICEPTIVE AND ANTIINFLAMMATORY PROPERTIES OF BP-2-94, A HISTAMINE H-3 RECEPTOR AGONIST PRODRUG, The Journal of pharmacology and experimental therapeutics, 281(3), 1997, pp. 1085-1094

Authors: HULS A PURAND K STARK H LIGNEAU X ARRANG JM SCHWARTZ JC SCHUNACK W
Citation: A. Huls et al., DIPHENYLMETHYL ETHERS - SYNTHESIS AND HISTAMINE H-3 RECEPTOR ANTAGONIST IN-VITRO AND IN-VIVO ACTIVITY, Bioorganic & medicinal chemistry letters, 6(16), 1996, pp. 2013-2018

Authors: HULS A PURAND K STARK H REIDEMEISTER S LIGNEAU X ARRANG JM SCHWARTZ JC SCHUNACK W
Citation: A. Huls et al., NOVEL HISTAMINE H-3 RECEPTOR ANTAGONISTS WITH BENZYL ETHER STRUCTURE OR RELATED MOIETIES - SYNTHESIS AND STRUCTURE-ACTIVITY-RELATIONSHIPS, Archiv der pharmazie, 329(8-9), 1996, pp. 379-385

Authors: DIMITRIADOU V ROULEAU A TUONG MDT LIGNEAU X NEWLANDS GFJ MILLER HRP SCHWARTZ JC GARBARG M
Citation: V. Dimitriadou et al., RAT CEREBRAL MAST-CELLS UNDERGO PHENOTYPIC CHANGES DURING DEVELOPMENT, Developmental brain research, 97(1), 1996, pp. 29-41

Authors: STARK H PURAND K HULS A LIGNEAU X GARBARG M SCHWARTZ JC SCHUNACK W
Citation: H. Stark et al., [I-125] IODOPROXYFAN AND RELATED-COMPOUNDS - A REVERSIBLE RADIOLIGANDAND NOVEL CLASSES OF ANTAGONISTS WITH HIGH-AFFINITY AND SELECTIVITY FOR THE HISTAMINE HS RECEPTOR, Journal of medicinal chemistry, 39(6), 1996, pp. 1220-1226

Authors: STARK H PURAND K LIGNEAU X ROULEAU A ARRANG JM GARBARG M SCHWARTZ JC SCHUNACK W
Citation: H. Stark et al., NOVEL CARBAMATES AS POTENT HISTAMINE H-3 RECEPTOR ANTAGONISTS WITH HIGH IN-VITRO AND ORAL IN-VIVO ACTIVITY, Journal of medicinal chemistry, 39(5), 1996, pp. 1157-1163

Authors: GANELLIN CR FKYERAT A BANGANDERSEN B ATHMANI S TERTIUK W GARBARG M LIGNEAU X SCHWARTZ JC
Citation: Cr. Ganellin et al., A NOVEL SERIES OF (PHENOXYALKYL)IMIDAZOLES AS POTENT H-3 RECEPTOR HISTAMINE-ANTAGONISTS, Journal of medicinal chemistry, 39(19), 1996, pp. 3806-3813

Authors: STARK H LIPP R ARRANG JM GARBARG M LIGNEAU X SCHWARTZ JC SCHUNACK W
Citation: H. Stark et al., NEW POTENT HISTAMINE H-3 RECEPTOR ANTAGONISTS OF THE AMIDE TYPE, European journal of pharmaceutical sciences, 3(2), 1995, pp. 95-104

Authors: KIECKONONOWICZ K LIGNEAU X STARK H SCHWARTZ JC SCHUNACK W
Citation: K. Kieckononowicz et al., AZINES AND DIAZINES AS POTENTIAL HISTAMIN E H-3 RECEPTOR ANTAGONISTS, Archiv der pharmazie, 328(5), 1995, pp. 445-450

Authors: KIECKONONOWICZ K LIGNEAU X SCHWARTZ JC SCHUNACK W
Citation: K. Kieckononowicz et al., PYRAZOLES AS POTENTIAL HISTAMINE H-3 RECE PTOR ANTAGONISTS, Archiv der pharmazie, 328(5), 1995, pp. 469-472

Authors: GANELLIN CR HOSSEINI SK KHALAF YS TERTIUK W ARRANG JM GARBARG M LIGNEAU X SCHWARTZ JC
Citation: Cr. Ganellin et al., DESIGN OF POTENT NON-THIOUREA H-3 RECEPTOR HISTAMINE-ANTAGONISTS, Journal of medicinal chemistry, 38(17), 1995, pp. 3342-3350

Authors: STARK H KRAUSE M ARRANG JM LIGNEAU X SCHWARTZ JC SCHUNACK W
Citation: H. Stark et al., UNSYMMETRICALLY SUBSTITUTED GUANIDINES AS POTENT HISTAMINE H-3 RECEPTOR ANTAGONISTS, Bioorganic & medicinal chemistry letters, 4(24), 1994, pp. 2907-2912

Authors: LIGNEAU X GARBARG M VIZUETE ML DIAZ J PURAND K STARK H SCHUNACK W SCHWARTZ JC
Citation: X. Ligneau et al., [I-125] IODOPROXYFAN, A NEW ANTAGONIST TO LABEL AND VISUALIZE CEREBRAL HISTAMINE H-3 RECEPTORS, The Journal of pharmacology and experimental therapeutics, 271(1), 1994, pp. 452-459
Risultati: 1-20 |